Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
about
Modeling of the bacterial mechanism of methicillin-resistance by a systems biology approachAntimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug ResistanceRecombinant antimicrobial peptide hPAB-β expressed in Pichia pastoris, a potential agent active against methicillin-resistant Staphylococcus aureus.Bacillus licheniformis BlaR1 L3 loop is a zinc metalloprotease activated by self-proteolysis.Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development.Role of vimA in cell surface biogenesis in Porphyromonas gingivalisBio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibioticsIn vitro antifungal activity of epigallocatechin 3-O-gallate against clinical isolates of dermatophytes.Letharia vulpina, a vulpinic acid containing lichen, targets cell membrane and cell division processes in methicillin-resistant Staphylococcus aureus.Cephalosporins in clinical development.Antimicrobial Effects and Resistant Regulation of Magnolol and Honokiol on Methicillin-Resistant Staphylococcus aureusPhenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.Towards rational treatment of bacterial infections during extended space travelAntigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression.Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.Emerging cephalosporins.Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus.Inhibitors targeting on cell wall biosynthesis pathway of MRSA.Key genetic elements and regulation systems in methicillin-resistant Staphylococcus aureus.Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies.Attenuation of quorum sensing-mediated virulence of Acinetobacter baumannii by Glycyrrhiza glabra flavonoids.Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines.Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective.The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus.Norgestimate inhibits staphylococcal biofilm formation and resensitizes methicillin-resistant Staphylococcus aureus to β-lactam antibiotics.Catechin Hydrate Augments the Antibacterial Action of Selected Antibiotics against Staphylococcus aureus Clinical Strains.Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells.A Molecular Docking and Dynamics Study to Screen Potent Anti-Staphylococcal Compounds Against Ceftaroline Resistant MRSA.VimA-dependent modulation of the secretome in Porphyromonas gingivalis.In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber model.Role of PBPD1 in stimulation of Listeria monocytogenes biofilm formation by subminimal inhibitory β-lactam concentrationsIsolation and characterization of cyclo-(tryptophanyl-prolyl) and chloramphenicol from Streptomyces sp. SUK 25 with antimethicillin-resistant Staphylococcus aureus activity.Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.The mechanism of antibacterial activity of phlorofucofuroeckol-A against methicillin-resistant Staphylococcus aureus.Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound.Synthesis and investigations on tellurium myconanoparticles.Performance of CHROMagar Staph aureus and CHROMagar MRSA for Detection of Airborne Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus
P2860
Q28475777-8C8FE820-F974-4DDE-AA34-B44AE41C30CDQ28552180-F2E93385-2799-44C0-9AD5-4513CE9FC265Q33698222-1A9183A5-98AB-4418-BE88-6C8293B75753Q34279713-8B848C2B-A517-40F5-BB14-A447BE23C5E9Q34407240-445ECBBF-FD71-468A-87A2-C6B08C57BE3FQ34746987-76C55129-4B2B-4688-A6DC-95E233C066FAQ34982564-C29E4876-E27C-46BA-A953-FD95B59BD1B0Q35003423-1F08228C-B746-44D9-B7CB-5F9E63576F0DQ35616818-1CACCDB9-B5D6-4E8B-9F9F-E2E6E3EE33F2Q35842532-CC50D9B8-88D4-4825-9598-6375A3933933Q36017541-D9EE1C3B-F75E-464C-943D-F1FF78CFFBC5Q36090275-2DE054AF-FDE9-4595-88DE-1CB8976EAC0CQ36238836-C65EE4DF-5E4C-4957-A9CA-8117DD3F3750Q36380959-A10D34BA-43C7-4546-AFB0-4D4F05CD1DEEQ36505342-616DD268-62C7-4A61-B758-368B5887DF13Q36882486-C2E7CC26-DC39-4138-A774-E8504408BDB4Q36989896-8D8A7638-DF49-4BE5-B4C1-BCF813D08A06Q37461413-988D7D7D-8F8C-44B3-A71F-4D014A5EEAF2Q38035171-48E91A41-EBD2-4D02-9307-99F6B4FC2750Q38052949-83ADE19F-C992-4E02-81F2-A12CA8F7C1F1Q38861856-5508CD35-942B-4BAB-9690-633D2EFBBD5DQ38941334-8B37BEF0-C9EE-40ED-9FEC-8E5B865689D4Q39160453-D35650BE-1A08-4FDF-A9E0-94793AB0F999Q39433962-88C28306-E8C9-456D-BDC2-2A5D20374636Q39720845-6B934A71-D27E-4101-B902-629AC7DCC07EQ40113756-C7EEB24E-DF65-46B0-937E-FF420FA27B79Q40780542-E05159E5-DB1E-4329-B042-1115E5C6F5ADQ40882710-5093C08B-114C-4DE5-995D-73539824CE20Q41064686-5EF029B7-4ED5-4961-A776-682E0345CE42Q41281749-0ABA27A4-584C-464F-9D94-8080E44FB71AQ41837870-283E6858-47D1-43EB-8D87-541001490B30Q42111513-33EEC2DA-5F79-42DA-8A0E-1EB90E67F42CQ42201298-C26E870F-E29E-43B6-9C20-DBD167833DFFQ42738610-435F26C0-B8A3-47EE-86DC-D32FD61E8217Q47097212-ADB890FC-A05D-4ABF-A17E-921B2F372888Q54190309-E36679F4-30A6-438A-A3F8-0E185EC77AE1Q55024892-27A6D2D8-2470-4D33-897A-3B1A836A3A8BQ55111057-BA5975C8-A809-49DC-B101-B3FDFF921DE0Q58286079-8EBB42BC-D5CC-4B46-B8CA-62A68F2089B3
P2860
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@ast
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@en
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@nl
type
label
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@ast
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@en
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@nl
prefLabel
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@ast
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@en
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@nl
P2860
P1476
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
@en
P2093
Paul D Stapleton
Peter W Taylor
P2860
P356
10.3184/003685002783238870
P577
2002-01-01T00:00:00Z